Wall Street analyst estimates for Hinge Health, Inc. (HNGE): consensus price target, buy/hold/sell recommendations and forecasts for revenue and EPS for the upcoming fiscal years.
Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.
Consensus price target
$103.92 (-11 % vs price $116.90)
between $76.00 and $140.00 · 12 targets published in the last quarter
Closing price, Oct 29
A twelve-month target is not a fair value: compare it with the range in the Valuation tab.
Revenue and EPS estimates
| Fiscal year | Revenue (average) | Revenue (low – high) | EPS (average) | Analysts |
|---|---|---|---|---|
| 2026E | $861M | $810M – $883M | $2.32 | 10 |
| 2027E | $1.1B | $982M – $1.2B | $2.93 | 9 |
Figures in USD · consensus as of October 29, 2026
Analyst Consensus
| Strong Buy | 0 |
| Buy | 15 |
| Hold | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 16 |
| Avg rating (−2 sell to +2 buy) | 0.94 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-02 | $0.57 | ||
| 2026-08-04 | $0.59 | $0.61 | -4.1% |
| 2026-05-05 | $0.45 | $0.39 | +15.4% |
| 2026-02-10 | $0.49 | $0.04 | +1125.0% |
| 2025-11-04 | $0.34 | $0.24 | +41.7% |
| 2025-08-05 | $0.67 | $0.09 | +644.4% |
| 2025-05-05 | $0.21 | $0.09 | +147.0% |
| 2025-03-10 | $0.35 |
Valuation Ratios
| P/E Ratio | 90.86 |
| Price / Book | 27.61 |
| EV / EBITDA | 87.09 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $292.7M | $390.4M | $587.9M |
| Cost of Revenue | $98.6M | $89.8M | $118.6M |
| Gross Profit | $194.2M | $300.6M | $469.3M |
| Research & Development | $110.1M | $100.8M | $368.1M |
| Selling, General & Admin | $214.6M | $227.5M | $639.4M |
| Operating Expenses | $324.7M | $332.5M | $1.02B |
| Operating Income | -$130.5M | -$31.9M | -$546.4M |
| EBITDA | -$124.9M | -$18.5M | -$535.9M |
| Interest Expense | 0 | 0 | 0 |
| Pre-tax Income | -$108.5M | -$11.3M | -$527.3M |
| Income Tax | -$405,000 | $677,000 | $998,000 |
| Net Income | -$108.1M | -$11.9M | -$528.3M |
| EPS | $-1.39 | $-0.15 | $-5.36 |
| EPS (Diluted) | $-1.39 | $-0.15 | $-5.19 |
| Shares Outstanding (Diluted) | 78.0 M | 78.0 M | 81.7 M |
Price
| Price | $116.90 (closing price, October 29, 2026) |
| Market Cap | $9.4B |
| Exchange | NYSE |
| Country | US |
Related companies: SNN · TEM · BTSG · HQY · DOCS · WAY · HTFL · PRVA
Explore sector: Healthcare · Medical - Healthcare Information Services
More sections of HNGE: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks